Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines
The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 22; no. 7; pp. 2113 - 2122 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
01.04.2014
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein. |
---|---|
AbstractList | The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein. The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein. (C) 2014 Elsevier Ltd. All rights reserved. The in vitro evaluation of thieno[3,2- d ]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein. |
Author | Gelbmann, Christopher Wilson, Gerald M. Temburnikar, Kartik W. Seley-Radtke, Katherine L. Salomon, Christine E. Zimmermann, Sarah C. Ross, Christina R. Kim, Nathaniel T. Balzarini, Jan |
AuthorAffiliation | d Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA a Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA b Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA c Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium |
AuthorAffiliation_xml | – name: b Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA – name: d Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA – name: c Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium – name: a Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA |
Author_xml | – sequence: 1 givenname: Kartik W. surname: Temburnikar fullname: Temburnikar, Kartik W. organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA – sequence: 2 givenname: Sarah C. surname: Zimmermann fullname: Zimmermann, Sarah C. organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA – sequence: 3 givenname: Nathaniel T. surname: Kim fullname: Kim, Nathaniel T. organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA – sequence: 4 givenname: Christina R. surname: Ross fullname: Ross, Christina R. organization: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA – sequence: 5 givenname: Christopher surname: Gelbmann fullname: Gelbmann, Christopher organization: Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA – sequence: 6 givenname: Christine E. surname: Salomon fullname: Salomon, Christine E. organization: Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA – sequence: 7 givenname: Gerald M. surname: Wilson fullname: Wilson, Gerald M. organization: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA – sequence: 8 givenname: Jan surname: Balzarini fullname: Balzarini, Jan organization: Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium – sequence: 9 givenname: Katherine L. surname: Seley-Radtke fullname: Seley-Radtke, Katherine L. email: kseley@umbc.edu organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24631358$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtrGzEUhUVJaJy0P6Cb4mWhmYleoxlRKASnj0Agm3ZVitBIV7HMWHIl2SX_vgp2TbspXV2BvnN0dc45OgkxAEKvCG4JJuJq1Y5r01JMeItpixl7hmaEC94wJskJmmEphgYPUpyh85xXGGPKJXmOzigXjLBumKGb61D8JsXJO0i6-B3MtanDFw95Ht18qaf4AEEXsPOy9BDiN3ZJG_t985j82lsfIL9Ap05PGV4e5gX6-vHDl8Xn5u7-0-3i-q4xfOCl0cBA4H6QlMpRdoJLznvmRkp7ojsuhMDOdEZYg3U_OAejZZ0jVhMJrHeSXaD3e9_NdlyDNRBK0pPa1EV0elRRe_X3TfBL9RB3inei47KvBm8OBin-2EIuau2zgWnSAeI2K9JRzCRmlFeU7FGTYs4J3PEZgtVT-mqlavrqKX2FqarpV83rP_c7Kn7HXYG3e-AnjNFlU-M0cMRqP4xxxvqhngip9PD_9MKXWl8Mi7gNpUrf7aVQ69h5SOogtz6BKcpG_49__ALwsbjb |
CitedBy_id | crossref_primary_10_1002_cmdc_201700641 crossref_primary_10_2174_0113852728266665231101112129 crossref_primary_10_1002_slct_202400563 crossref_primary_10_1021_acs_jmedchem_0c01100 crossref_primary_10_1134_S1070428020110147 crossref_primary_10_1016_j_bmcl_2015_02_071 crossref_primary_10_1080_15421406_2019_1706268 crossref_primary_10_1002_slct_202400514 crossref_primary_10_1590_0001_3765201820170798 crossref_primary_10_1515_hc_2015_0160 crossref_primary_10_1002_chem_201501334 crossref_primary_10_1016_j_tiv_2019_05_009 crossref_primary_10_1055_s_0042_1751508 crossref_primary_10_1016_j_heliyon_2018_e00661 crossref_primary_10_1016_j_ejmech_2019_112024 crossref_primary_10_3390_molecules22050788 crossref_primary_10_3390_molecules24142656 crossref_primary_10_1134_S1070428016040187 crossref_primary_10_1039_C7RA04261B crossref_primary_10_1016_j_molstruc_2023_137022 crossref_primary_10_1515_acph_2017_0028 crossref_primary_10_3390_ph15010035 crossref_primary_10_1016_j_ijms_2020_116411 crossref_primary_10_1016_j_bmc_2015_06_025 |
Cites_doi | 10.1021/jo0155613 10.1016/j.cell.2011.02.013 10.1021/jm0601809 10.1021/ol101482h 10.1021/jm2009327 10.1158/1535-7163.MCT-11-0446 10.1038/cdd.2008.131 10.1016/j.canlet.2010.12.012 10.1021/jm901284w 10.1021/ja9064359 10.1186/1476-4598-10-35 10.1016/j.bmc.2004.12.011 10.1016/j.tet.2007.01.075 10.1021/jo400913k 10.1080/15257770.2012.656212 10.1038/nrc1587 10.1081/NCN-200027660 10.1021/jm3003747 10.1016/j.bmc.2006.06.046 10.1016/j.bmcl.2003.10.030 10.1021/ml200198x 10.1021/jm000326i 10.2144/000113089 10.1021/ml100230n 10.1021/jm300016v 10.1016/j.canlet.2010.09.012 10.1021/jm800295d 10.1084/jem.97.5.695 10.1002/jhet.5570240354 10.1046/j.1359-4117.2002.01002.x 10.1021/jo00154a005 10.1016/S0040-4039(00)78826-5 10.1002/jhet.5570230631 10.1016/0040-4039(81)80031-7 10.1021/jm9903949 10.2174/1874467210801030244 10.1016/0022-1759(95)00072-I 10.1021/jm00117a019 10.1080/15257779408011862 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J 10.1021/jo00155a026 10.1021/jm981012m 10.1021/jo00145a005 10.1021/jm00014a027 10.1055/s-1974-23448 10.1016/j.tet.2008.09.011 10.1093/nass/nrn321 10.1080/15257779408011866 |
ContentType | Journal Article |
Copyright | 2014 Elsevier Ltd Copyright © 2014 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier Ltd – notice: Copyright © 2014 Elsevier Ltd. All rights reserved. |
DBID | 1KM BLEPL DTL GNMZZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 8FD FR3 P64 5PM |
DOI | 10.1016/j.bmc.2014.02.033 |
DatabaseName | Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science - Science Citation Index Expanded - 2014 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Engineering Research Database MEDLINE Web of Science |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1464-3391 |
EndPage | 2122 |
ExternalDocumentID | 10_1016_j_bmc_2014_02_033 24631358 000334337800011 S0968089614001394 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA grantid: R01GM073645 – fundername: NCI NIH HHS grantid: R01 CA102428 – fundername: NIGMS NIH HHS grantid: R01GM073645 KSR – fundername: NIGMS NIH HHS grantid: R01 GM073645 – fundername: NIGMS NIH HHS grantid: T32 GM066706 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM LCYCR LZ2 M29 M2Z M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPC SPCBC SSH SSK SSP SSU SSZ T5K UPT XPP YK3 ~02 ~G- 1KM AAXKI AKRWK BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED CGR CUY CVF ECM EIF NPM 53G AAQXK AAYXX ACNNM ADMUD AFFNX AFJKZ AGHFR AGRDE ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HEA HMK HMO HMS HMT HVGLF HZ~ R2- SAE SCB SEW SOC SPT WUQ ZMT 7QO 8FD FR3 P64 5PM |
ID | FETCH-LOGICAL-c484t-ae3e60789229b956494473fb2271a546660fc5c6dc0a78ffebd35f1da19e37f93 |
IEDL.DBID | .~1 |
ISICitedReferencesCount | 32 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000334337800011 |
ISSN | 0968-0896 |
IngestDate | Tue Sep 17 21:24:14 EDT 2024 Sat Oct 05 06:09:33 EDT 2024 Thu Sep 26 16:01:19 EDT 2024 Sat Nov 02 11:55:40 EDT 2024 Wed Sep 18 09:18:52 EDT 2024 Fri Nov 08 20:01:02 EST 2024 Fri Feb 23 02:30:56 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Thieno[3,2-d]pyrimidine Heterocyclic chemistry Antifungal Cytostatic Apoptosis DESIGN SERIES KINASE INHIBITOR CANCER DISCOVERY POTENT PI3 KINASE BIOLOGICAL EVALUATION C-NUCLEOSIDE ISOSTERE DERIVATIVES |
Language | English |
License | Copyright © 2014 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c484t-ae3e60789229b956494473fb2271a546660fc5c6dc0a78ffebd35f1da19e37f93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ORCID | 0000-0002-0154-3459 0000-0003-4976-598X 0000-0002-1273-7507 |
OpenAccessLink | https://europepmc.org/articles/pmc4565497?pdf=render |
PMID | 24631358 |
PQID | 1520390324 |
PQPubID | 23462 |
PageCount | 10 |
ParticipantIDs | webofscience_primary_000334337800011 webofscience_primary_000334337800011CitationCount pubmed_primary_24631358 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4565497 elsevier_sciencedirect_doi_10_1016_j_bmc_2014_02_033 proquest_miscellaneous_1520390324 crossref_primary_10_1016_j_bmc_2014_02_033 |
PublicationCentury | 2000 |
PublicationDate | 2014-04-01 |
PublicationDateYYYYMMDD | 2014-04-01 |
PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | OXFORD |
PublicationPlace_xml | – name: OXFORD – name: England |
PublicationTitle | Bioorganic & medicinal chemistry |
PublicationTitleAbbrev | BIOORGAN MED CHEM |
PublicationTitleAlternate | Bioorg Med Chem |
PublicationYear | 2014 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Fossey, Landelle, Laduree, Robba (b0110) 1994; 13 Munchhof, Beebe, Casavant, Cooper, Doty, Higdon, Hillerman, Soderstrom, Knauth, Marx, Rossi, Sobolov, Sun (b0060) 2004; 14 Sutherlin, Sampath, Berry, Castanedo, Chang, Chuckowree, Dotson, Folkes, Friedman, Goldsmith, Heffron, Lee, Lesnick, Lewis, Mathieu, Nonomiya, Olivero, Pang, Prior, Salphati, Sideris, Tian, Tsui, Wan, Wang, Wiesmann, Wong, Zhu (b0080) 2010; 53 Mathieu, Gradl, Ren, Wen, Aliagas, Gunzner-Toste, Lee, Pulk, Zhao, Alicke, Boggs, Buckmelter, Choo, Dinkel, Gloor, Gould, Hansen, Hastings, Hatzivassiliou, Laird, Moreno, Ran, Voegtli, Wenglowsky, Grina, Rudolph (b0095) 2012; 55 Wallace, Candlish, Hagos, Seley, De Koning (b0135) 2004; 23 Fossey, Laduree, Robba (b0105) 1994; 13 Guimaraes, Kopecky, Mihalic, Shen, Jeffries, Thibault, Chen, Walker, Cardozo (b0180) 2009; 131 Lemke, T. L.; Williams, D. A.; Editors Foye’s Principles of Medicinal Chemistry: Fifth edition, 2002. Seley, Januszczyk, Hagos, Zhang, Dransfield (b0055) 2000; 43 Shi, Du, Ma, Pankiewicz, Patterson, Tharnish, McBrayer, Stuyver, Otto, Chu, Schinazi, Watanabe (b0160) 2005; 13 Foley, Lazarus, Farber, Uzman, Boone, McCarthy (b0195) 1965; 18 Lim, Klein, Fox (b0010) 1980; 21 Lim, Ren, Otter, Klein (b0025) 1983; 48 Joule, J. A.; Mills, K. Heterocyclic Chemistry: Fourth Edition, 2000. Cory, Chen, Cory (b0240) 2006; 26 Ren, Rao, Klein (b0030) 1986; 23 Showalter, Bridges, Zhou, Sercel, McMichael, Fry (b0050) 1999; 42 ‘Performance Standards for Antimicrobial Susceptibility Testing: 14th Informational Supplement’, National Committee for Clinical Laboratory Standards, 2004. Eisele, Weller (b0260) 2013; 332 Ren, Lim, Otter, Klein (b0015) 1982; 47 Mollard, Warner, Call, Wade, Bearss, Verma, Sharma, Vankayalapati, Bearss (b0210) 2011; 2 Sutherlin, Bao, Berry, Castanedo, Chuckowree, Dotson, Folks, Friedman, Goldsmith, Gunzner, Heffron, Lesnick, Lewis, Mathieu, Murray, Nonomiya, Pang, Pegg, Prior, Rouge, Salphati, Sampath, Tian, Tsui, Wan, Wang, Wei, Wiesmann, Wu, Zhu, Olivero (b0085) 2011; 54 Pore, Hiltermann, Kruyt (b0265) 2013; 332 Vermes, Haanen, Steffens-Nakken, Reutelingsperger (b0275) 1995; 184 Neidle, Thurston (b0225) 2005; 5 Safina, Baker, Baumgardner, Blaney, Chan, Chen, Cartwright, Castanedo, Chabot, Cheguillaume, Goldsmith, Goldstein, Goyal, Hancox, Handa, Iyer, Kaur, Kondru, Kenny, Krintel, Li, Lesnick, Lucas, Lewis, Mukadam, Murray, Nadin, Nonomiya, Padilla, Palmer, Pang, Pegg, Price, Reif, Salphati, Savy, Seward, Shuttleworth, Sohal, Sweeney, Tay, Tivitmahaisoon, Waszkowycz, Wei, Yue, Zhang, Sutherlin (b0100) 2012; 55 Girgis, Cottam, Larson, Robins (b0185) 1987; 24 Bourke, Burns, Cuzzupe, Feutrill, Kling, Nero (b0150) 2009 Ife, Brown, Blurton, Keeling, Leach, Meeson, Parsons, Theobald (b0040) 1995; 38 Tor, Del Valle, Jaramillo, Srivatsan, Rios, Weizman (b0115) 2007; 63 Temburnikar, Zhang, Seley-Radtke (b0145) 2012; 31 Evans, Furneaux, Hutchison, Kezar, Morris, Schramm, Tyler (b0175) 2001; 66 Kikuchi, Yamamoto, Horoiwa, Hirai, Kasahara, Hariguchi, Matsumoto, Oshima (b0065) 2006; 49 Seley-Radtke, Zhang, Wauchope, Zimmermann, Ivanov, Korba (b0120) 2008; 52 Hayakawa, Kaizawa, Moritomo, Koizumi, Ohishi, Okada, Ohta, Tsukamoto, Parker, Workman, Waterfield (b0070) 2006; 14 Kelly, Lopez-Chavez, Citrin, Janik, Morris (b0255) 2011; 10 Cupps, Wise, Townsend (b0170) 1983; 48 Hanahan, Weinberg Robert (b0250) 2011; 144 Bravo-Altamirano, George, Frantz, LaValle, Tandon, Leimgruber, Sharlow, Lazo, Wang, Wipf (b0155) 2011; 2 Lim, Klein (b0020) 1981; 22 Wade, L. G. Organic Chemistry, 4th Edition, 1998. Wallin, Edgar, Guan, Berry, Prior, Lee, Lesnick, Lewis, Nonomiya, Pang, Salphati, Olivero, Sutherlin, O’Brien, Spoerke, Patel, Lensun, Kassees, Ross, Lackner, Sampath, Belvin, Friedman (b0090) 2011; 10 Rahbari, R.; Sheahan, T.; Modes, V.; Collier, P.; Macfarlane, C.; Badge, R. M. BioTechniques 2009, 46, 277–278, 280, 282, 284. Zhang, Wauchope, Seley-Radtke (b0125) 2008; 64 Law, Dunn (b0190) 1949; 10 Temburnikar, Brace, Seley-Radtke (b0140) 2013; 78 Maiuri, Tasdemir, Criollo, Morselli, Vicencio, Carnuccio, Kroemer (b0235) 2009; 16 Scherer, Syverton, Gey (b0200) 1953; 97 Russell, Press, Rampulla, McNally, Falotico, Keiser, Bright, Tobia (b0035) 1988; 31 Wauchope, Tomney, Pepper, Korba, Seley-Radtke (b0130) 2010; 12 Sullivan, Garcia-Welch, White, Lutzker, Hait (b0245) 2002; 2 Richardson, Kaye (b0270) 2008; 1 Crespo, Pages, Vega, Segarra, Lopez, Domenech, Miralpeix, Beleta, Ryder, Palacios (b0045) 1998; 41 Folkes, Ahmadi, Alderton, Alix, Baker, Box, Chuckowree, Clarke, Depledge, Eccles, Friedman, Hayes, Hancox, Kugendradas, Lensun, Moore, Olivero, Pang, Patel, Pergl-Wilson, Raynaud, Robson, Saghir, Salphati, Sohal, Ultsch, Valenti, Wallweber, Wan, Wiesmann, Workman, Zhyvoloup, Zvelebil, Shuttleworth (b0075) 2008; 51 Amarnath, Madhav (b0005) 1974 (b0230) 2002 Kelly, RJ (WOS:000289941600001) 2011; 10 (000334337800011.40) 1000 LIM, MI (WOS:A1983QH60600005) 1983; 48 Seley, KL (WOS:000165866100017) 2000; 43 FOLEY, GE (WOS:A19656307400016) 1965; 18 Sutherlin, DP (WOS:000296408100014) 2011; 54 Rahbari, R (WOS:000266095900005) 2009; 46 LAW, LW (WOS:A1949UF24900018) 1949; 10 Hayakawa, M (WOS:000241227400006) 2006; 14 Joule, J. A. (000334337800011.19) 2000; Fourth REN, WY (WOS:A1982PR58400005) 1982; 47 (000334337800011.4) 2002 Richardson, Alan (MEDLINE:20021437) 2008; 1 (000334337800011.23) 1000 Neidle, S (WOS:000228091000014) 2005; 5 LIM, MI (WOS:A1981KX03600007) 1981; 22 Folkes, AJ (WOS:000259342700007) 2008; 51 (000334337800011.1) 1000 Pore, MM (WOS:000318378200027) 2013; 332 Mathieu, S (WOS:000301767000029) 2012; 55 Shi, JX (WOS:000227251300024) 2005; 13 Bravo-Altamirano, K (WOS:000287297200012) 2011; 2 Wallace, LJM (WOS:000225113700069) 2004; 23 Wallin, JJ (WOS:000298344400021) 2011; 10 LIM, MI (WOS:A1980JH42000007) 1980; 21 Maiuri, MC (WOS:000261693600011) 2009; 16 CUPPS, TL (WOS:A1983QK09500026) 1983; 48 Mollard, A (WOS:000297947000007) 2011; 2 Temburnikar, K (WOS:000322210700051) 2013; 78 Sutherlin, DP (WOS:000274270900016) 2010; 53 Eisele, G (WOS:000318378200025) 2013; 332 Wauchope, OR (WOS:000282604700009) 2010; 12 Safina, BS (WOS:000305769600018) 2012; 55 FOSSEY, C (WOS:A1994NL49000005) 1994; 13 REN, WY (WOS:A1986F587500031) 1986; 23 Temburnikar, K (WOS:000303579100004) 2012; 31 GIRGIS, NS (WOS:A1987H627300054) 1987; 24 Crespo, MI (WOS:000076374300013) 1998; 41 Kikuchi, H (WOS:000239141500029) 2006; 49 AMARNATH, V (WOS:A1974V163200001) 1974 (000334337800011.51) 1000 FOSSEY, C (WOS:A1994NL49000001) 1994; 13 Sullivan, Gregory F (MEDLINE:12415616); 2 Tor, Y (WOS:000248294800021) 2007; 63 Guimaraes, CRW (WOS:000273615400037) 2009; 131 Zhang, ZB (WOS:000260703200002) 2008; 64 Evans, GB (WOS:000170598900011) 2001; 66 SCHERER, WF (WOS:A1953UD35500008) 1953; 97 Showalter, HDH (WOS:000084640000015) 1999; 42 Cory, AH (WOS:000236674800063) 2006; 26 VERMES, I (WOS:A1995RL33700005) 1995; 184 RUSSELL, RK (WOS:A1988P883100019) 1988; 31 IFE, RJ (WOS:A1995RJ01400027) 1995; 38 Munchhof, MJ (WOS:000187862000001) 2004; 14 Hanahan, D (WOS:000288007100007) 2011; 144 Mollard (10.1016/j.bmc.2014.02.033_b0210) 2011; 2 Shi (10.1016/j.bmc.2014.02.033_b0160) 2005; 13 Ren (10.1016/j.bmc.2014.02.033_b0015) 1982; 47 Zhang (10.1016/j.bmc.2014.02.033_b0125) 2008; 64 Sutherlin (10.1016/j.bmc.2014.02.033_b0080) 2010; 53 Crespo (10.1016/j.bmc.2014.02.033_b0045) 1998; 41 Wallace (10.1016/j.bmc.2014.02.033_b0135) 2004; 23 Scherer (10.1016/j.bmc.2014.02.033_b0200) 1953; 97 Ren (10.1016/j.bmc.2014.02.033_b0030) 1986; 23 (10.1016/j.bmc.2014.02.033_b0230) 2002 Seley-Radtke (10.1016/j.bmc.2014.02.033_b0120) 2008; 52 10.1016/j.bmc.2014.02.033_b0215 Mathieu (10.1016/j.bmc.2014.02.033_b0095) 2012; 55 Amarnath (10.1016/j.bmc.2014.02.033_b0005) 1974 Showalter (10.1016/j.bmc.2014.02.033_b0050) 1999; 42 Guimaraes (10.1016/j.bmc.2014.02.033_b0180) 2009; 131 Fossey (10.1016/j.bmc.2014.02.033_b0110) 1994; 13 Neidle (10.1016/j.bmc.2014.02.033_b0225) 2005; 5 Kelly (10.1016/j.bmc.2014.02.033_b0255) 2011; 10 10.1016/j.bmc.2014.02.033_b0220 Tor (10.1016/j.bmc.2014.02.033_b0115) 2007; 63 Temburnikar (10.1016/j.bmc.2014.02.033_b0140) 2013; 78 Safina (10.1016/j.bmc.2014.02.033_b0100) 2012; 55 Vermes (10.1016/j.bmc.2014.02.033_b0275) 1995; 184 Lim (10.1016/j.bmc.2014.02.033_b0020) 1981; 22 Foley (10.1016/j.bmc.2014.02.033_b0195) 1965; 18 10.1016/j.bmc.2014.02.033_b0205 Law (10.1016/j.bmc.2014.02.033_b0190) 1949; 10 Folkes (10.1016/j.bmc.2014.02.033_b0075) 2008; 51 Seley (10.1016/j.bmc.2014.02.033_b0055) 2000; 43 Maiuri (10.1016/j.bmc.2014.02.033_b0235) 2009; 16 Ife (10.1016/j.bmc.2014.02.033_b0040) 1995; 38 Temburnikar (10.1016/j.bmc.2014.02.033_b0145) 2012; 31 Bravo-Altamirano (10.1016/j.bmc.2014.02.033_b0155) 2011; 2 Wallin (10.1016/j.bmc.2014.02.033_b0090) 2011; 10 Hayakawa (10.1016/j.bmc.2014.02.033_b0070) 2006; 14 Lim (10.1016/j.bmc.2014.02.033_b0025) 1983; 48 Lim (10.1016/j.bmc.2014.02.033_b0010) 1980; 21 Hanahan (10.1016/j.bmc.2014.02.033_b0250) 2011; 144 Richardson (10.1016/j.bmc.2014.02.033_b0270) 2008; 1 Cupps (10.1016/j.bmc.2014.02.033_b0170) 1983; 48 Pore (10.1016/j.bmc.2014.02.033_b0265) 2013; 332 Kikuchi (10.1016/j.bmc.2014.02.033_b0065) 2006; 49 Evans (10.1016/j.bmc.2014.02.033_b0175) 2001; 66 Munchhof (10.1016/j.bmc.2014.02.033_b0060) 2004; 14 Bourke (10.1016/j.bmc.2014.02.033_b0150) 2009 Girgis (10.1016/j.bmc.2014.02.033_b0185) 1987; 24 Sullivan (10.1016/j.bmc.2014.02.033_b0245) 2002; 2 Russell (10.1016/j.bmc.2014.02.033_b0035) 1988; 31 Fossey (10.1016/j.bmc.2014.02.033_b0105) 1994; 13 10.1016/j.bmc.2014.02.033_b0165 Cory (10.1016/j.bmc.2014.02.033_b0240) 2006; 26 Eisele (10.1016/j.bmc.2014.02.033_b0260) 2013; 332 Sutherlin (10.1016/j.bmc.2014.02.033_b0085) 2011; 54 10.1016/j.bmc.2014.02.033_b0280 Wauchope (10.1016/j.bmc.2014.02.033_b0130) 2010; 12 |
References_xml | – volume: 144 start-page: 646 year: 2011 ident: b0250 publication-title: Cell contributor: fullname: Weinberg Robert – volume: 64 start-page: 10791 year: 2008 ident: b0125 publication-title: Tetrahedron contributor: fullname: Seley-Radtke – volume: 24 start-page: 821 year: 1987 ident: b0185 publication-title: J. Heterocycl. Chem. contributor: fullname: Robins – volume: 13 start-page: 925 year: 1994 ident: b0110 article-title: Nucleosides publication-title: Nucleotides Nucleic Acids contributor: fullname: Robba – volume: 41 start-page: 4021 year: 1998 ident: b0045 publication-title: J. Med. Chem. contributor: fullname: Palacios – volume: 49 start-page: 4698 year: 2006 ident: b0065 publication-title: J. Med. Chem. contributor: fullname: Oshima – volume: 52 start-page: 635 year: 2008 ident: b0120 publication-title: Nucleic Acids Symp. Ser. contributor: fullname: Korba – year: 2002 ident: b0230 publication-title: The Molecular Basis of Human Cancer – volume: 47 start-page: 4633 year: 1982 ident: b0015 publication-title: J. Org. Chem. contributor: fullname: Klein – volume: 23 start-page: 1441 year: 2004 ident: b0135 article-title: Nucleosides publication-title: Nucleotides Nucleic Acids contributor: fullname: De Koning – volume: 184 start-page: 39 year: 1995 ident: b0275 publication-title: J. Immunol. Methods contributor: fullname: Reutelingsperger – volume: 23 start-page: 1757 year: 1986 ident: b0030 publication-title: J. Heterocycl. Chem. contributor: fullname: Klein – volume: 10 start-page: 2426 year: 2011 ident: b0090 publication-title: Mol. Cancer Ther. contributor: fullname: Friedman – volume: 78 start-page: 7305 year: 2013 ident: b0140 publication-title: J. Org. Chem. contributor: fullname: Seley-Radtke – volume: 55 start-page: 2869 year: 2012 ident: b0095 publication-title: J. Med. Chem. contributor: fullname: Rudolph – volume: 13 start-page: 1641 year: 2005 ident: b0160 publication-title: Bioorg. Med. Chem. contributor: fullname: Watanabe – volume: 10 start-page: 179 year: 1949 ident: b0190 publication-title: J. Natl. Cancer. Inst. contributor: fullname: Dunn – volume: 48 start-page: 1060 year: 1983 ident: b0170 publication-title: J. Org. Chem. contributor: fullname: Townsend – volume: 1 start-page: 244 year: 2008 ident: b0270 publication-title: Curr. Mol. Pharmacol. contributor: fullname: Kaye – year: 2009 ident: b0150 article-title: Cytopia Research Pty Ltd, Australia contributor: fullname: Nero – volume: 63 start-page: 3608 year: 2007 ident: b0115 publication-title: Tetrahedron contributor: fullname: Weizman – volume: 26 start-page: 1289 year: 2006 ident: b0240 publication-title: Anticancer Res. contributor: fullname: Cory – volume: 53 start-page: 1086 year: 2010 ident: b0080 publication-title: J. Med. Chem. contributor: fullname: Zhu – volume: 55 start-page: 5887 year: 2012 ident: b0100 publication-title: J. Med. Chem. contributor: fullname: Sutherlin – volume: 18 start-page: 522 year: 1965 ident: b0195 publication-title: Cancer contributor: fullname: McCarthy – volume: 2 start-page: 19 year: 2002 ident: b0245 publication-title: J. Exp. Ther. Oncol. contributor: fullname: Hait – volume: 2 start-page: 154 year: 2011 ident: b0155 publication-title: ACS Med. Chem. Lett. contributor: fullname: Wipf – volume: 97 start-page: 695 year: 1953 ident: b0200 publication-title: J. Exp. Med. contributor: fullname: Gey – volume: 21 start-page: 1013 year: 1980 ident: b0010 publication-title: Tetrahedron Lett. contributor: fullname: Fox – volume: 66 start-page: 5723 year: 2001 ident: b0175 publication-title: J. Org. Chem. contributor: fullname: Tyler – volume: 38 start-page: 2763 year: 1995 ident: b0040 publication-title: J. Med. Chem. contributor: fullname: Theobald – volume: 43 start-page: 4877 year: 2000 ident: b0055 publication-title: J. Med. Chem. contributor: fullname: Dransfield – volume: 14 start-page: 6847 year: 2006 ident: b0070 publication-title: Bioorg. Med. Chem. contributor: fullname: Waterfield – volume: 22 start-page: 25 year: 1981 ident: b0020 publication-title: Tetrahedron Lett. contributor: fullname: Klein – volume: 2 start-page: 907 year: 2011 ident: b0210 publication-title: ACS Med. Chem. Lett. contributor: fullname: Bearss – volume: 5 start-page: 285 year: 2005 ident: b0225 publication-title: Nat. Rev. Cancer contributor: fullname: Thurston – volume: 54 start-page: 7579 year: 2011 ident: b0085 publication-title: J. Med. Chem. contributor: fullname: Olivero – volume: 10 start-page: 35 year: 2011 ident: b0255 publication-title: Mol. Cancer contributor: fullname: Morris – volume: 13 start-page: 883 year: 1994 ident: b0105 article-title: Nucleosides publication-title: Nucleotides Nucleic Acids contributor: fullname: Robba – volume: 332 start-page: 359 year: 2013 ident: b0265 publication-title: Cancer Lett. contributor: fullname: Kruyt – volume: 12 start-page: 4466 year: 2010 ident: b0130 publication-title: Org. Lett. contributor: fullname: Seley-Radtke – start-page: 837 year: 1974 ident: b0005 publication-title: Synthesis contributor: fullname: Madhav – volume: 31 start-page: 319 year: 2012 ident: b0145 publication-title: Nucleosides, Nucleotides, Nucleic Acids contributor: fullname: Seley-Radtke – volume: 42 start-page: 5464 year: 1999 ident: b0050 publication-title: J. Med. Chem. contributor: fullname: Fry – volume: 131 start-page: 18139 year: 2009 ident: b0180 publication-title: J. Am. Chem. Soc. contributor: fullname: Cardozo – volume: 16 start-page: 87 year: 2009 ident: b0235 publication-title: Cell Death Differ. contributor: fullname: Kroemer – volume: 332 start-page: 335 year: 2013 ident: b0260 publication-title: Cancer Lett. contributor: fullname: Weller – volume: 51 start-page: 5522 year: 2008 ident: b0075 publication-title: J. Med. Chem. contributor: fullname: Shuttleworth – volume: 14 start-page: 21 year: 2004 ident: b0060 publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Sun – volume: 48 start-page: 780 year: 1983 ident: b0025 publication-title: J. Org. Chem. contributor: fullname: Klein – volume: 31 start-page: 1786 year: 1988 ident: b0035 publication-title: J. Med. Chem. contributor: fullname: Tobia – volume: 66 start-page: 5723 year: 2001 ident: WOS:000170598900011 article-title: Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: Convergent synthesis of the aza-C-nucleoside immucillins publication-title: JOURNAL OF ORGANIC CHEMISTRY doi: 10.1021/jo0155613 contributor: fullname: Evans, GB – volume: 144 start-page: 646 year: 2011 ident: WOS:000288007100007 article-title: Hallmarks of Cancer: The Next Generation publication-title: CELL doi: 10.1016/j.cell.2011.02.013 contributor: fullname: Hanahan, D – year: 1000 ident: 000334337800011.40 publication-title: NUCL ACIDS S SER – volume: 49 start-page: 4698 year: 2006 ident: WOS:000239141500029 article-title: Exploration of a new type of antimalarial compounds based on febrifugine publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm0601809 contributor: fullname: Kikuchi, H – volume: 24 start-page: 821 year: 1987 ident: WOS:A1987H627300054 article-title: 9-DEAZAPURINE NUCLEOSIDES - THE SYNTHESIS OF CERTAIN N-5-2'-DEOXY-BETA-D-ERYTHROPENTOFURANOSYL AND N-5-BETA-D-ARABINOFURANOSYLPYRROLO[3,2-D]PYRIMIDINES publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY contributor: fullname: GIRGIS, NS – volume: 64 start-page: 10791 year: 2008 ident: WOS:000260703200002 article-title: Mechanistic studies in the synthesis of a series of thieno-expanded xanthosine and guanosine nucleosides publication-title: TETRAHEDRON contributor: fullname: Zhang, ZB – volume: 97 start-page: 695 year: 1953 ident: WOS:A1953UD35500008 article-title: STUDIES ON THE PROPAGATION INVITRO OF POLIOMYELITIS VIRUSES .4. VIRAL MULTIPLICATION IN A STABLE STRAIN OF HUMAN MALIGNANT EPITHELIAL CELLS (STRAIN HELA) DERIVED FROM AN EPIDERMOID CARCINOMA OF THE CERVIX publication-title: JOURNAL OF EXPERIMENTAL MEDICINE contributor: fullname: SCHERER, WF – volume: 13 start-page: 883 year: 1994 ident: WOS:A1994NL49000001 article-title: SYNTHESIS OF ACYCLIC THIENO[3,2-D]PYRIMIDINE NUCLEOSIDES AND AZIDO DERIVATIVES AS POTENTIAL ANTI-HIV AGENTS publication-title: NUCLEOSIDES & NUCLEOTIDES contributor: fullname: FOSSEY, C – start-page: 837 year: 1974 ident: WOS:A1974V163200001 article-title: SURVEY OF METHODS FOR PREPARATION OF PYRROLOPYRIMIDINES publication-title: SYNTHESIS-STUTTGART contributor: fullname: AMARNATH, V – volume: 22 start-page: 25 year: 1981 ident: WOS:A1981KX03600007 article-title: SYNTHESIS OF 9-DEAZAADENOSINE - A NEW CYTO-TOXIC C-NUCLEOSIDE ISOSTERE OF ADENOSINE publication-title: TETRAHEDRON LETTERS contributor: fullname: LIM, MI – volume: 12 start-page: 4466 year: 2010 ident: WOS:000282604700009 article-title: Tricyclic 2 '-C-Modified Nucleosides as Potential Anti-HCV Therapeutics publication-title: ORGANIC LETTERS doi: 10.1021/ol101482h contributor: fullname: Wauchope, OR – volume: 54 start-page: 7579 year: 2011 ident: WOS:000296408100014 article-title: Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm2009327 contributor: fullname: Sutherlin, DP – volume: 41 start-page: 4021 year: 1998 ident: WOS:000076374300013 article-title: Design, synthesis, and biological activities of new thieno[3,2-d]pyrimidines as selective type 4 phosphodiesterase inhibitors publication-title: JOURNAL OF MEDICINAL CHEMISTRY contributor: fullname: Crespo, MI – volume: 10 start-page: 2426 year: 2011 ident: WOS:000298344400021 article-title: GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway publication-title: MOLECULAR CANCER THERAPEUTICS doi: 10.1158/1535-7163.MCT-11-0446 contributor: fullname: Wallin, JJ – volume: 31 start-page: 1786 year: 1988 ident: WOS:A1988P883100019 article-title: THIOPHENE SYSTEMS .9. THIENOPYRIMIDINEDIONE DERIVATIVES AS POTENTIAL ANTIHYPERTENSIVE AGENTS publication-title: JOURNAL OF MEDICINAL CHEMISTRY contributor: fullname: RUSSELL, RK – volume: 16 start-page: 87 year: 2009 ident: WOS:000261693600011 article-title: Control of autophagy by oncogenes and tumor suppressor genes publication-title: CELL DEATH AND DIFFERENTIATION doi: 10.1038/cdd.2008.131 contributor: fullname: Maiuri, MC – volume: 1 start-page: 244 year: 2008 ident: MEDLINE:20021437 article-title: Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy. publication-title: Current molecular pharmacology contributor: fullname: Richardson, Alan – volume: 332 start-page: 335 year: 2013 ident: WOS:000318378200025 article-title: Targeting apoptosis pathways in glioblastoma publication-title: CANCER LETTERS doi: 10.1016/j.canlet.2010.12.012 contributor: fullname: Eisele, G – volume: 184 start-page: 39 year: 1995 ident: WOS:A1995RL33700005 article-title: A NOVEL ASSAY FOR APOPTOSIS - FLOW CYTOMETRIC DETECTION OF PHOSPHATIDYLSERINE EXPRESSION ON EARLY APOPTOTIC CELLS USING FLUORESCEIN-LABELED ANNEXIN-V publication-title: JOURNAL OF IMMUNOLOGICAL METHODS contributor: fullname: VERMES, I – volume: 53 start-page: 1086 year: 2010 ident: WOS:000274270900016 article-title: Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm901284w contributor: fullname: Sutherlin, DP – volume: 131 start-page: 18139 year: 2009 ident: WOS:000273615400037 article-title: Thermodynamic Analysis of mRNA Cap Binding by the Human Initiation Factor eIF4E via Free Energy Perturbations publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja9064359 contributor: fullname: Guimaraes, CRW – volume: 10 start-page: ARTN 35 year: 2011 ident: WOS:000289941600001 article-title: Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin publication-title: MOLECULAR CANCER doi: 10.1186/1476-4598-10-35 contributor: fullname: Kelly, RJ – volume: 10 start-page: 179 year: 1949 ident: WOS:A1949UF24900018 article-title: OBSERVATIONS ON THE EFFECT OF A FOLIC-ACID ANTAGONIST ON TRANSPLANTABLE LYMPHOID LEUKEMIAS IN MICE publication-title: JOURNAL OF THE NATIONAL CANCER INSTITUTE contributor: fullname: LAW, LW – volume: 38 start-page: 2763 year: 1995 ident: WOS:A1995RJ01400027 article-title: REVERSIBLE INHIBITORS OF THE GASTRIC (H+/K+)-ATPASE .5. SUBSTITUTED 2,4-DIAMINOQUINAZOLINES AND THIENOPYRIMIDINES publication-title: JOURNAL OF MEDICINAL CHEMISTRY contributor: fullname: IFE, RJ – year: 1000 ident: 000334337800011.1 publication-title: PERF STAND ANT SUSC – volume: 13 start-page: 1641 year: 2005 ident: WOS:000227251300024 article-title: Synthesis and anti-viral activity of a series of D- and L-2 '-deoxy-2 '-fluororibonucleosides in the subgenomic HCV replicon system publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2004.12.011 contributor: fullname: Shi, JX – volume: 63 start-page: 3608 year: 2007 ident: WOS:000248294800021 article-title: Designing new isomorphic fluorescent nucleobase analogues: the thieno[3,2-d]pyrimidine core publication-title: TETRAHEDRON doi: 10.1016/j.tet.2007.01.075 contributor: fullname: Tor, Y – volume: 78 start-page: 7305 year: 2013 ident: WOS:000322210700051 article-title: Synthesis of 2 '-Deoxy-9-deaza Nucleosides Using Heck Methodology publication-title: JOURNAL OF ORGANIC CHEMISTRY doi: 10.1021/jo400913k contributor: fullname: Temburnikar, K – volume: 31 start-page: 319 year: 2012 ident: WOS:000303579100004 article-title: MODIFIED SYNTHESIS OF 3 '-OTBDPS-PROTECTED FURANOID GLYCAL publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS doi: 10.1080/15257770.2012.656212 contributor: fullname: Temburnikar, K – year: 1000 ident: 000334337800011.51 publication-title: ORGANIC CHEM – volume: 23 start-page: 1757 year: 1986 ident: WOS:A1986F587500031 article-title: CONVENIENT SYNTHESIS OF SUBSTITUTED 3-AMINOTHIOPHENE-2-CARBONITRILES FROM ALPHA-ACETYLENIC NITRILES AND THEIR CONVERSION TO THIENO[3,2-D]PYRIMIDINES publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY contributor: fullname: REN, WY – volume: 42 start-page: 5464 year: 1999 ident: WOS:000084640000015 article-title: Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3,2-d]pyrimidines and pyrimido[5,4-b]- and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase publication-title: JOURNAL OF MEDICINAL CHEMISTRY contributor: fullname: Showalter, HDH – volume: Fourth year: 2000 ident: 000334337800011.19 publication-title: Heterocyclic Chemistry contributor: fullname: Joule, J. A. – volume: 5 start-page: 285 year: 2005 ident: WOS:000228091000014 article-title: Chemical approaches to the discovery and development of cancer therapies publication-title: NATURE REVIEWS CANCER doi: 10.1038/nrc1587 contributor: fullname: Neidle, S – year: 2002 ident: 000334337800011.4 publication-title: MOL BASIS HUMAN CANC – volume: 21 start-page: 1013 year: 1980 ident: WOS:A1980JH42000007 article-title: SYNTHESIS OF THE PYRROLO[3,2-D]PYRIMIDINE C-NUCLEOSIDE ISOSTERE OF INOSINE publication-title: TETRAHEDRON LETTERS contributor: fullname: LIM, MI – volume: 18 start-page: 522 year: 1965 ident: WOS:A19656307400016 article-title: CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA publication-title: CANCER contributor: fullname: FOLEY, GE – volume: 23 start-page: 1441 year: 2004 ident: WOS:000225113700069 article-title: Selective transport of a new class of purine antimetabolites by the protozoan parasite Trypanosoma brucei publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS doi: 10.1081/NCN-200027660 contributor: fullname: Wallace, LJM – volume: 55 start-page: 5887 year: 2012 ident: WOS:000305769600018 article-title: Discovery of Novel PI3-Kinase delta Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm3003747 contributor: fullname: Safina, BS – volume: 14 start-page: 6847 year: 2006 ident: WOS:000241227400006 article-title: Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110 alpha inhibitors publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2006.06.046 contributor: fullname: Hayakawa, M – volume: 26 start-page: 1289 year: 2006 ident: WOS:000236674800063 article-title: Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: Necrosis vs. apoptosis publication-title: ANTICANCER RESEARCH contributor: fullname: Cory, AH – volume: 14 start-page: 21 year: 2004 ident: WOS:000187862000001 article-title: Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2003.10.030 contributor: fullname: Munchhof, MJ – volume: 2 start-page: 907 year: 2011 ident: WOS:000297947000007 article-title: Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors publication-title: ACS MEDICINAL CHEMISTRY LETTERS doi: 10.1021/ml200198x contributor: fullname: Mollard, A – volume: 43 start-page: 4877 year: 2000 ident: WOS:000165866100017 article-title: Synthesis and antitumor activity of thieno-separated tricyclic purines publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm000326i contributor: fullname: Seley, KL – volume: 46 start-page: 277 year: 2009 ident: WOS:000266095900005 article-title: A novel L1 retrotransposon marker for HeLa cell line identification publication-title: BIOTECHNIQUES doi: 10.2144/000113089 contributor: fullname: Rahbari, R – volume: 2 start-page: 19 ident: MEDLINE:12415616 article-title: Augmentation of apoptosis by the combination of bleomycin with trifluoperazine in the presence of mutant p53. publication-title: Journal of experimental therapeutics & oncology contributor: fullname: Sullivan, Gregory F – year: 1000 ident: 000334337800011.23 publication-title: FOYES PRINCIPLES MED – volume: 13 start-page: 925 year: 1994 ident: WOS:A1994NL49000005 article-title: SYNTHESIS OF N-1-BETA-D-ARABINOFURANOSYL AND N-1-2'-DEOXY-BETA-D-ERYTHRO-PENTOFURANOSYL THIENO[3,2-D]PYRIMIDINE NUCLEOSIDES publication-title: NUCLEOSIDES & NUCLEOTIDES contributor: fullname: FOSSEY, C – volume: 48 start-page: 1060 year: 1983 ident: WOS:A1983QK09500026 article-title: SYNTHETIC STRATEGIES TOWARD THE SYNTHESIS OF 2,4-DIMETHOXYPYRROLO[3,2-D]PYRIMIDINE publication-title: JOURNAL OF ORGANIC CHEMISTRY contributor: fullname: CUPPS, TL – volume: 48 start-page: 780 year: 1983 ident: WOS:A1983QH60600005 article-title: SYNTHESIS OF 9-DEAZAGUANOSINE AND OTHER NEW PYRROLO[3,2-D]PYRIMIDINE C-NUCLEOSIDES publication-title: JOURNAL OF ORGANIC CHEMISTRY contributor: fullname: LIM, MI – volume: 47 start-page: 4633 year: 1982 ident: WOS:A1982PR58400005 article-title: SYNTHETIC STUDIES OF THE THIENO[3,2-D]PYRIMIDINE C-NUCLEOSIDE ISOSTERE OF INOSINE publication-title: JOURNAL OF ORGANIC CHEMISTRY contributor: fullname: REN, WY – volume: 2 start-page: 154 year: 2011 ident: WOS:000287297200012 article-title: Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D publication-title: ACS MEDICINAL CHEMISTRY LETTERS doi: 10.1021/ml100230n contributor: fullname: Bravo-Altamirano, K – volume: 55 start-page: 2869 year: 2012 ident: WOS:000301767000029 article-title: Potent and Selective Aminopyrimidine-Based B-Raf Inhibitors with Favorable Physicochemical and Pharmacokinetic Properties publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm300016v contributor: fullname: Mathieu, S – volume: 332 start-page: 359 year: 2013 ident: WOS:000318378200027 article-title: Targeting apoptosis pathways in lung cancer publication-title: CANCER LETTERS doi: 10.1016/j.canlet.2010.09.012 contributor: fullname: Pore, MM – volume: 51 start-page: 5522 year: 2008 ident: WOS:000259342700007 article-title: The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm800295d contributor: fullname: Folkes, AJ – volume: 332 start-page: 359 year: 2013 ident: 10.1016/j.bmc.2014.02.033_b0265 publication-title: Cancer Lett. doi: 10.1016/j.canlet.2010.09.012 contributor: fullname: Pore – volume: 97 start-page: 695 year: 1953 ident: 10.1016/j.bmc.2014.02.033_b0200 publication-title: J. Exp. Med. doi: 10.1084/jem.97.5.695 contributor: fullname: Scherer – volume: 5 start-page: 285 year: 2005 ident: 10.1016/j.bmc.2014.02.033_b0225 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1587 contributor: fullname: Neidle – volume: 24 start-page: 821 year: 1987 ident: 10.1016/j.bmc.2014.02.033_b0185 publication-title: J. Heterocycl. Chem. doi: 10.1002/jhet.5570240354 contributor: fullname: Girgis – volume: 2 start-page: 19 year: 2002 ident: 10.1016/j.bmc.2014.02.033_b0245 publication-title: J. Exp. Ther. Oncol. doi: 10.1046/j.1359-4117.2002.01002.x contributor: fullname: Sullivan – volume: 48 start-page: 780 year: 1983 ident: 10.1016/j.bmc.2014.02.033_b0025 publication-title: J. Org. Chem. doi: 10.1021/jo00154a005 contributor: fullname: Lim – volume: 21 start-page: 1013 year: 1980 ident: 10.1016/j.bmc.2014.02.033_b0010 publication-title: Tetrahedron Lett. doi: 10.1016/S0040-4039(00)78826-5 contributor: fullname: Lim – ident: 10.1016/j.bmc.2014.02.033_b0280 – volume: 23 start-page: 1757 year: 1986 ident: 10.1016/j.bmc.2014.02.033_b0030 publication-title: J. Heterocycl. Chem. doi: 10.1002/jhet.5570230631 contributor: fullname: Ren – ident: 10.1016/j.bmc.2014.02.033_b0220 – volume: 26 start-page: 1289 year: 2006 ident: 10.1016/j.bmc.2014.02.033_b0240 publication-title: Anticancer Res. contributor: fullname: Cory – volume: 31 start-page: 319 year: 2012 ident: 10.1016/j.bmc.2014.02.033_b0145 publication-title: Nucleosides, Nucleotides, Nucleic Acids doi: 10.1080/15257770.2012.656212 contributor: fullname: Temburnikar – volume: 22 start-page: 25 year: 1981 ident: 10.1016/j.bmc.2014.02.033_b0020 publication-title: Tetrahedron Lett. doi: 10.1016/0040-4039(81)80031-7 contributor: fullname: Lim – volume: 42 start-page: 5464 year: 1999 ident: 10.1016/j.bmc.2014.02.033_b0050 publication-title: J. Med. Chem. doi: 10.1021/jm9903949 contributor: fullname: Showalter – volume: 1 start-page: 244 year: 2008 ident: 10.1016/j.bmc.2014.02.033_b0270 publication-title: Curr. Mol. Pharmacol. doi: 10.2174/1874467210801030244 contributor: fullname: Richardson – volume: 16 start-page: 87 year: 2009 ident: 10.1016/j.bmc.2014.02.033_b0235 publication-title: Cell Death Differ. doi: 10.1038/cdd.2008.131 contributor: fullname: Maiuri – volume: 184 start-page: 39 year: 1995 ident: 10.1016/j.bmc.2014.02.033_b0275 publication-title: J. Immunol. Methods doi: 10.1016/0022-1759(95)00072-I contributor: fullname: Vermes – volume: 31 start-page: 1786 year: 1988 ident: 10.1016/j.bmc.2014.02.033_b0035 publication-title: J. Med. Chem. doi: 10.1021/jm00117a019 contributor: fullname: Russell – volume: 63 start-page: 3608 year: 2007 ident: 10.1016/j.bmc.2014.02.033_b0115 publication-title: Tetrahedron doi: 10.1016/j.tet.2007.01.075 contributor: fullname: Tor – volume: 144 start-page: 646 year: 2011 ident: 10.1016/j.bmc.2014.02.033_b0250 publication-title: Cell doi: 10.1016/j.cell.2011.02.013 contributor: fullname: Hanahan – year: 2009 ident: 10.1016/j.bmc.2014.02.033_b0150 contributor: fullname: Bourke – volume: 13 start-page: 883 year: 1994 ident: 10.1016/j.bmc.2014.02.033_b0105 article-title: Nucleosides publication-title: Nucleotides Nucleic Acids doi: 10.1080/15257779408011862 contributor: fullname: Fossey – volume: 14 start-page: 6847 year: 2006 ident: 10.1016/j.bmc.2014.02.033_b0070 publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2006.06.046 contributor: fullname: Hayakawa – volume: 18 start-page: 522 year: 1965 ident: 10.1016/j.bmc.2014.02.033_b0195 publication-title: Cancer doi: 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J contributor: fullname: Foley – volume: 43 start-page: 4877 year: 2000 ident: 10.1016/j.bmc.2014.02.033_b0055 publication-title: J. Med. Chem. doi: 10.1021/jm000326i contributor: fullname: Seley – volume: 10 start-page: 2426 year: 2011 ident: 10.1016/j.bmc.2014.02.033_b0090 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-11-0446 contributor: fullname: Wallin – volume: 48 start-page: 1060 year: 1983 ident: 10.1016/j.bmc.2014.02.033_b0170 publication-title: J. Org. Chem. doi: 10.1021/jo00155a026 contributor: fullname: Cupps – volume: 55 start-page: 2869 year: 2012 ident: 10.1016/j.bmc.2014.02.033_b0095 publication-title: J. Med. Chem. doi: 10.1021/jm300016v contributor: fullname: Mathieu – volume: 10 start-page: 35 year: 2011 ident: 10.1016/j.bmc.2014.02.033_b0255 publication-title: Mol. Cancer doi: 10.1186/1476-4598-10-35 contributor: fullname: Kelly – volume: 41 start-page: 4021 year: 1998 ident: 10.1016/j.bmc.2014.02.033_b0045 publication-title: J. Med. Chem. doi: 10.1021/jm981012m contributor: fullname: Crespo – volume: 78 start-page: 7305 year: 2013 ident: 10.1016/j.bmc.2014.02.033_b0140 publication-title: J. Org. Chem. doi: 10.1021/jo400913k contributor: fullname: Temburnikar – volume: 131 start-page: 18139 year: 2009 ident: 10.1016/j.bmc.2014.02.033_b0180 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja9064359 contributor: fullname: Guimaraes – volume: 47 start-page: 4633 year: 1982 ident: 10.1016/j.bmc.2014.02.033_b0015 publication-title: J. Org. Chem. doi: 10.1021/jo00145a005 contributor: fullname: Ren – volume: 12 start-page: 4466 year: 2010 ident: 10.1016/j.bmc.2014.02.033_b0130 publication-title: Org. Lett. doi: 10.1021/ol101482h contributor: fullname: Wauchope – volume: 332 start-page: 335 year: 2013 ident: 10.1016/j.bmc.2014.02.033_b0260 publication-title: Cancer Lett. doi: 10.1016/j.canlet.2010.12.012 contributor: fullname: Eisele – volume: 38 start-page: 2763 year: 1995 ident: 10.1016/j.bmc.2014.02.033_b0040 publication-title: J. Med. Chem. doi: 10.1021/jm00014a027 contributor: fullname: Ife – volume: 53 start-page: 1086 year: 2010 ident: 10.1016/j.bmc.2014.02.033_b0080 publication-title: J. Med. Chem. doi: 10.1021/jm901284w contributor: fullname: Sutherlin – volume: 10 start-page: 179 year: 1949 ident: 10.1016/j.bmc.2014.02.033_b0190 publication-title: J. Natl. Cancer. Inst. contributor: fullname: Law – year: 2002 ident: 10.1016/j.bmc.2014.02.033_b0230 – ident: 10.1016/j.bmc.2014.02.033_b0215 – volume: 55 start-page: 5887 year: 2012 ident: 10.1016/j.bmc.2014.02.033_b0100 publication-title: J. Med. Chem. doi: 10.1021/jm3003747 contributor: fullname: Safina – volume: 54 start-page: 7579 year: 2011 ident: 10.1016/j.bmc.2014.02.033_b0085 publication-title: J. Med. Chem. doi: 10.1021/jm2009327 contributor: fullname: Sutherlin – start-page: 837 year: 1974 ident: 10.1016/j.bmc.2014.02.033_b0005 publication-title: Synthesis doi: 10.1055/s-1974-23448 contributor: fullname: Amarnath – volume: 51 start-page: 5522 year: 2008 ident: 10.1016/j.bmc.2014.02.033_b0075 publication-title: J. Med. Chem. doi: 10.1021/jm800295d contributor: fullname: Folkes – volume: 66 start-page: 5723 year: 2001 ident: 10.1016/j.bmc.2014.02.033_b0175 publication-title: J. Org. Chem. doi: 10.1021/jo0155613 contributor: fullname: Evans – ident: 10.1016/j.bmc.2014.02.033_b0205 doi: 10.2144/000113089 – volume: 64 start-page: 10791 year: 2008 ident: 10.1016/j.bmc.2014.02.033_b0125 publication-title: Tetrahedron doi: 10.1016/j.tet.2008.09.011 contributor: fullname: Zhang – volume: 2 start-page: 907 year: 2011 ident: 10.1016/j.bmc.2014.02.033_b0210 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml200198x contributor: fullname: Mollard – volume: 2 start-page: 154 year: 2011 ident: 10.1016/j.bmc.2014.02.033_b0155 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml100230n contributor: fullname: Bravo-Altamirano – ident: 10.1016/j.bmc.2014.02.033_b0165 – volume: 14 start-page: 21 year: 2004 ident: 10.1016/j.bmc.2014.02.033_b0060 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2003.10.030 contributor: fullname: Munchhof – volume: 52 start-page: 635 year: 2008 ident: 10.1016/j.bmc.2014.02.033_b0120 publication-title: Nucleic Acids Symp. Ser. doi: 10.1093/nass/nrn321 contributor: fullname: Seley-Radtke – volume: 13 start-page: 925 year: 1994 ident: 10.1016/j.bmc.2014.02.033_b0110 article-title: Nucleosides publication-title: Nucleotides Nucleic Acids doi: 10.1080/15257779408011866 contributor: fullname: Fossey – volume: 49 start-page: 4698 year: 2006 ident: 10.1016/j.bmc.2014.02.033_b0065 publication-title: J. Med. Chem. doi: 10.1021/jm0601809 contributor: fullname: Kikuchi – volume: 23 start-page: 1441 year: 2004 ident: 10.1016/j.bmc.2014.02.033_b0135 article-title: Nucleosides publication-title: Nucleotides Nucleic Acids doi: 10.1081/NCN-200027660 contributor: fullname: Wallace – volume: 13 start-page: 1641 year: 2005 ident: 10.1016/j.bmc.2014.02.033_b0160 publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2004.12.011 contributor: fullname: Shi |
SSID | ssj0002491 |
Score | 2.3079338 |
Snippet | The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer... The in vitro evaluation of thieno[3,2- d ]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer... |
Source | Web of Science |
SourceID | pubmedcentral proquest crossref pubmed webofscience elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2113 |
SubjectTerms | Anti-Bacterial Agents - chemical synthesis Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antifungal Antifungal Agents - chemical synthesis Antifungal Agents - chemistry Antifungal Agents - pharmacology Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Apoptosis Apoptosis - drug effects Bacillus subtilis - drug effects Biochemistry & Molecular Biology Cell Cycle - drug effects Cell Proliferation - drug effects Chemistry Chemistry, Medicinal Chemistry, Organic Cytostatic Dose-Response Relationship, Drug Drug Screening Assays, Antitumor Fungi - drug effects Heterocyclic chemistry Humans Life Sciences & Biomedicine Microbial Sensitivity Tests Molecular Structure Pharmacology & Pharmacy Physical Sciences Pyrimidines - chemical synthesis Pyrimidines - chemistry Pyrimidines - pharmacology Science & Technology Structure-Activity Relationship Thieno[3,2-d]pyrimidine Tumor Cells, Cultured |
Title | Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines |
URI | https://dx.doi.org/10.1016/j.bmc.2014.02.033 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000334337800011 https://www.ncbi.nlm.nih.gov/pubmed/24631358 https://search.proquest.com/docview/1520390324 https://pubmed.ncbi.nlm.nih.gov/PMC4565497 |
Volume | 22 |
WOS | 000334337800011 |
WOSCitedRecordID | wos000334337800011 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrQRcEGx5pEAVpIoDImxiO3F8XC1UC6i9QKVKCFlObGsXqdkVTSv10t_eGSdZWF5CHJPYkTVjz3xjj78BOFCZFdwpmWSssAkaPJMYWauEFxgP1TlT3tNt5KPjYnYi3p_mp1swHe7CUFplb_s7mx6sdf9m3EtzvFosxh8RfJdpqdC_BBxDnKAC3R_O6dfX39M8MLwIVfOwcUKth5PNkONVnRGLYSYCbSfnf_JNv2LP36dQ_uS2gos6vAd3e2wZT7rh34ct14xgd9JgXH12Fb-IQ7Zn2EYfwe3pUOltBLeO-gP2XXgzadrFiir5eNdxgsd08-Ey8K7GSx_PabPH4S-djds5DmP5mb9iif2yuqICYZay6B_AyeHbT9NZ0hdaSGpRijYxjruCeOcZUxUGTEIJIbmvGJOZyQVGOKmv87qwdWpk6b2rLM99Zk2mHJde8Yew3Swb9xhiKVxdIYqQtE9ifFpVBteh9cIbz9OKRfByELFedXwaekg0-6pRH5r0oVOmUR8RiEEJemNSaLT3f-v2fFCYRknSCYhp3PLiXCNYSblKEURG8KhT4HoUTBQ843kZgdxQ7boBEXFvfmkW80DITahYKBnBwY-TYN2R4k4uOJdlQOARZP_SbNpztBM3Qbv3f5J4Anfoqcs0egrb7bcL9wxBVFvth1WyDzuTdx9mxzcn2hqf |
link.rule.ids | 230,315,783,787,888,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NITFeEHT8CDAI0sQDImtiO3H8WHVMBda9sEmTELKcxFaLtLTaMqS98Ldz5yQdZYAQr7EdWXf23Xf2-TuAXZVUglslo4RlVYQGz0RGliriGcZDZcqUc_QaeXqUTU7Eh9P0dAPG_VsYSqvsbH9r07217r4MO2kOl_P58BOC7zzOFfoXj2PELbgtCB_jot77fp3ngfGFL5uHvSPq3l9t-iSv4oxoDBPheTs5_5Nzugk-f59D-Yvf8j7q4D7c68BlOGrn_wA2bD2A7VGNgfXZVfg69Ome_hx9AFvjvtTbAO5Muxv2bdgf1c18SaV8nG1JwUN6-vDNE6-GCxfO6LTH4i9tFTYznMbiM3_LourL8ooqhFWURv8QTg7eHY8nUVdpISpFLprIWG4zIp5nTBUYMQklhOSuYEwmJhUY4sSuTMusKmMjc-dsUfHUJZVJlOXSKf4INutFbZ9AKIUtC4QRkg5KjIuLwuBGrJxwxvG4YAG86UWsly2hhu4zzb5q1IcmfeiYadRHAKJXgl5bFRoN_t-GveoVplGSdAViaru4vNCIVmKuYkSRATxuFbiaBRMZT3iaByDXVLvqQEzc6y31fOYZuQkWCyUD2P15EawGUuDJBecy9xA8gORfuo07knYiJ2ie_p8kXsLW5Hh6qA_fH318BneppU07eg6bzfml3UFE1RQv_I75AZBKHDg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiproliferative+activities+of+halogenated+thieno%5B3%2C2-d%5Dpyrimidines&rft.jtitle=Bioorganic+%26+medicinal+chemistry&rft.au=Temburnikar%2C+Kartik+W&rft.au=Zimmermann%2C+Sarah+C&rft.au=Kim%2C+Nathaniel+T&rft.au=Ross%2C+Christina+R&rft.date=2014-04-01&rft.issn=0968-0896&rft.volume=22&rft.issue=7&rft.spage=2113&rft.epage=2122&rft_id=info:doi/10.1016%2Fj.bmc.2014.02.033&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0968-0896&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0968-0896&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0968-0896&client=summon |